Sulfamethoxazole Export Market Intelligence: India's 145 Suppliers Shipping to 92 Countries — TransData Nexus 2026

Q: Who are the top sulfamethoxazole exporters from India?

The top sulfamethoxazole exporters from India are: 1. MICRO LABS LIMITED — $7.3M (36.8% market share); 2. AUROBINDO PHARMA LIMITED — $1.1M (5.6% market share); 3. FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED — $1.0M (5.3% market share); 4. APL HEALTHCARE LIMITED — $891.1K (4.5% market share); 5. AMNEAL PHARMACEUTICALS PRIVATE LIMITED — $744.8K (3.8% market share). Together they account for 55.9% of India's total sulfamethoxazole export value.

Q: What is the total export value of sulfamethoxazole from India?

The total export value of sulfamethoxazole from India is $19.8M USD, recorded across 877 shipment transactions from 145 active exporters to 92 destination countries. The average shipment value is $22.5K.

Q: Which countries import sulfamethoxazole from India?

India exports sulfamethoxazole to 92 countries worldwide. The top importing countries are: ZIMBABWE (20.0% share, $3.9M), UNITED STATES (18.9% share, $3.7M), SOUTH AFRICA (5.5% share, $1.1M), TANZANIA (3.7% share, $734.0K), BURKINA FASO (3.5% share, $682.2K). These five markets account for 51.5% of total export value.

Q: What is the average price of sulfamethoxazole exports from India?

The average unit price for sulfamethoxazole exports from India is $12.23 USD per unit, with prices ranging from $0.01 to $332.36 depending on formulation, packaging, and order volume. The total market is valued at $19.8M across 877 shipments.

Q: Which ports handle sulfamethoxazole exports from India?

The primary ports for sulfamethoxazole exports from India are NHAVA SHEVA SEA (INNSA1) (9.7% of shipments), JNPT/ NHAVA SHEVA SEA (9.5% of shipments), SAHAR AIR (8.2% of shipments), JNPT (7.4% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.1% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of sulfamethoxazole?

India is one of the world's leading exporters of sulfamethoxazole due to its large base of 145 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports sulfamethoxazole to 92 countries, demonstrating 47% global market coverage.

Q: What certifications do Indian sulfamethoxazole exporters need?

Indian sulfamethoxazole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import sulfamethoxazole from India?

There are 266 registered buyers importing sulfamethoxazole from India, spread across 92 countries. The repeat buyer rate is 52.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top sulfamethoxazole supplier from India?

MICRO LABS LIMITED is the leading sulfamethoxazole exporter from India with a market share of 36.8% and total export value of $7.3M across 111 shipments. The top 5 suppliers together control 55.9% of total export value.

Suresh Sormare

Sulfamethoxazole

India Pharmaceutical Trade Intelligence

$19.8M145 Suppliers92 CountriesHS 30042020

ExportsIndia → ZIMBABWE20.0%India → UNITED STATES18.9%

ImportsGERMANY → India$74.8K UNITED KINGDOM → India$1.6K

#1 Supplier: MICRO LABS #1 Buyer: MINISTRY OF

Sulfamethoxazole Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Sulfamethoxazole to the World

Between 2022 and 2026, India exported $19.8M worth of sulfamethoxazole across 877 verified shipments to 92 countries — covering 47% of world markets in the Advanced Antibiotics segment. The largest destination is ZIMBABWE (20.0%). MICRO LABS LIMITED leads with a 36.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Sulfamethoxazole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Sulfamethoxazole export data snapshot — $19.8M · 145 exporters · 92 countriesTransData Nexus · Indian Customs Data

Top Sulfamethoxazole Exporters from India

145 active exporters · Ranked by export value

View all 145 →

Top Sulfamethoxazole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MICRO LABS LIMITED	$7.3M	111	19	36.8%
2	AUROBINDO PHARMA LIMITED

Top Countries Importing Sulfamethoxazole from India

92 destination markets · Ranked by import value

All 92 countries →

Top Countries Importing Sulfamethoxazole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	ZIMBABWE	$3.9M	20.0%
2	UNITED STATES	$3.7M	18.9%
3	SOUTH AFRICA	$1.1M	5.5%
4	TANZANIA	$734.0K	3.7%
5	BURKINA FASO	$682.2K	3.5%
6	SUDAN	$671.9K	3.4%
7	BURUNDI	$657.7K	3.3%
8	FRANCE	$631.4K	3.2%
9	RUSSIA	$534.7K	2.7%
10	ETHIOPIA	$435.4K	2.2%

ZIMBABWE is India's largest sulfamethoxazole export destination, absorbing 20.0% of total exports worth $3.9M. The top 5 importing countries — ZIMBABWE, UNITED STATES, SOUTH AFRICA, TANZANIA, BURKINA FASO — together account for 51.5% of India's total sulfamethoxazole export value. The remaining 87 destination countries collectively receive the other 48.5%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Sulfamethoxazole to India?

5 origin countries · Total import value: $76.5K

India imports sulfamethoxazole from 5 countries with a combined import value of $76.5K. The largest supplier is GERMANY ($74.8K, 16 shipments), followed by UNITED KINGDOM and SOUTH AFRICA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Sulfamethoxazole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$74.8K	16	97.8%
2	UNITED KINGDOM	$1.6K	2	2.1%
3	SOUTH AFRICA	$93	11	0.1%
4	AUSTRALIA	$9	1	0.0%
5	UNITED STATES	$8	5	0.0%

GERMANY is the largest supplier of sulfamethoxazole to India, accounting for 97.8% of total import value. The top 5 origin countries — GERMANY, UNITED KINGDOM, SOUTH AFRICA, AUSTRALIA, UNITED STATES — together supply 100.0% of India's sulfamethoxazole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Sulfamethoxazole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, sulfamethoxazole is commonly marketed in combination with trimethoprim as a generic drug. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for this combination, indicating a well-established generic market. The most recent approval was granted in March 2025. Given that 145 Indian exporters are active in the sulfamethoxazole market, it is imperative for these entities to ensure compliance with FDA regulations, including adherence to Current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA). As of March 2026, there are no active FDA import alerts specifically targeting sulfamethoxazole products from India, suggesting a favorable regulatory environment for Indian exporters.

2EU & UK Regulatory Framework

In the European Union, sulfamethoxazole, in combination with trimethoprim, is authorized for marketing under various national procedures. The European Medicines Agency (EMA) oversees the harmonization of these authorizations to ensure consistent safety and efficacy standards across member states. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) continues to regulate sulfamethoxazole post-Brexit, maintaining alignment with EU standards. Compliance with EU Good Manufacturing Practice (GMP) guidelines is mandatory for manufacturers exporting to these regions, necessitating regular inspections and certifications to uphold product quality and safety.

3WHO Essential Medicines & Global Standards

Sulfamethoxazole, in combination with trimethoprim, has been included in the World Health Organization's Model List of Essential Medicines since its first edition in 1977. The 24th edition, published in September 2025, continues to list this combination, underscoring its critical role in treating bacterial infections. The combination is also featured in the WHO Essential Medicines List for Children, highlighting its importance in pediatric care. Manufacturers must ensure that their products meet the standards set forth in recognized pharmacopoeias, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to facilitate global acceptance and compliance.

4India Regulatory Classification

In India, sulfamethoxazole, when combined with trimethoprim, is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not imposed a ceiling price on this combination as of March 2026, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products; however, sulfamethoxazole is not currently subject to this requirement, streamlining the export process for manufacturers.

5Patent & Exclusivity Status

The primary patents for sulfamethoxazole and its combination with trimethoprim have long expired, resulting in a competitive generic market. This expiration has facilitated the entry of multiple manufacturers, including the 145 active Indian exporters, contributing to the widespread availability and affordability of the drug globally.

6Recent Industry Developments

In June 2025, the World Health Organization updated its Essential Medicines List, reaffirming the inclusion of sulfamethoxazole-trimethoprim combination, reflecting its ongoing importance in global health. In September 2025, the WHO published the 24th edition of the Model List of Essential Medicines, continuing to list the sulfamethoxazole-trimethoprim combination, underscoring its critical role in treating bacterial infections. In December 2025, the Indian Ministry of Health and Family Welfare announced a revision of the National List of Essential Medicines, which includes the sulfamethoxazole-trimethoprim combination, aligning with WHO recommendations. In February 2026, the European Medicines Agency issued updated guidelines on the manufacturing of antibiotics, emphasizing stricter compliance with GMP standards, directly impacting Indian exporters targeting the EU market. In March 2026, the US FDA released a report highlighting the need for enhanced monitoring of antibiotic resistance patterns, including those related to sulfamethoxazole-trimethoprim, urging manufacturers to invest in surveillance and reporting mechanisms.

These developments underscore the dynamic regulatory landscape surrounding sulfamethoxazole, necessitating continuous vigilance and compliance from Indian exporters to maintain and expand their global market presence.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Sulfamethoxazole

Retail & reference prices across 9 markets vs. India FOB export price of $12.23/unit

Global Price Benchmark for Sulfamethoxazole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Data not available	USD	The FDA Orange Book lists approved formulations of Sulfamethoxazole and Trimethoprim, but specific pricing data is not provided.
United Kingdom	Data not available	GBP	The NHS Drug Tariff includes Sulfamethoxazole and Trimethoprim, but specific pricing information is not detailed.
Germany	Data not available	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates pharmaceuticals, including Sulfamethoxazole and Trimethoprim, but specific pricing data is not publicly disclosed.

Supply Chain Risk Assessment — Sulfamethoxazole

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of sulfamethoxazole, heavily relies on imports for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). Approximately 70–80% of India's API and KSM requirements are sourced from China, underscoring a significant dependency on Chinese suppliers. This reliance exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or production issues within China.

Efforts to mitigate this dependency have been initiated through the Production Linked Incentive (PLI) scheme, aiming to bolster domestic manufacturing of critical APIs and KSMs. Notably, two greenfield plants were inaugurated in October 2024 to produce essential molecules like Penicillin G and 6-APA, which are vital for various antibiotics. These developments are expected to reduce India's import dependence on key pharmaceutical ingredients by half.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of sulfamethoxazole from India account for 55.9% of the total export value, with MICRO LABS LIMITED alone contributing 36.8%. This concentration suggests a moderate risk associated with supplier dependency. While the PLI scheme has made strides in enhancing domestic production capabilities, the full impact on diversifying the supplier base for sulfamethoxazole remains to be seen.

Access Complete Sulfamethoxazole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 877 transactions across 92 markets.

Request Demo View Pricing

Frequently Asked Questions — Sulfamethoxazole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top sulfamethoxazole exporters from India?

The leading sulfamethoxazole exporters from India are MICRO LABS LIMITED, AUROBINDO PHARMA LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED, and 11 others. MICRO LABS LIMITED leads with 36.8% market share ($7.3M). The top 5 suppliers together control 55.9% of total export value.

What is the total export value of sulfamethoxazole from India?

The total export value of sulfamethoxazole from India is $19.8M, recorded across 877 shipments from 145 active exporters to 92 countries. The average shipment value is $22.5K.

Which countries import sulfamethoxazole from India?

India exports sulfamethoxazole to 92 countries. The top importing countries are ZIMBABWE (20.0%), UNITED STATES (18.9%), SOUTH AFRICA (5.5%), TANZANIA (3.7%), BURKINA FASO (3.5%), which together account for 51.5% of total export value.

What is the HS code for sulfamethoxazole exports from India?

The primary HS code for sulfamethoxazole exports from India is 30042020. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Sulfamethoxazole

Sulfamethoxazole

Top Sulfamethoxazole Exporters from India

Top Countries Importing Sulfamethoxazole from India

Who Supplies Sulfamethoxazole to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Sulfamethoxazole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Sulfamethoxazole

Supply Chain Risk Assessment — Sulfamethoxazole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Sulfamethoxazole Trade Intelligence

Frequently Asked Questions — Sulfamethoxazole Exports from India

Who are the top sulfamethoxazole exporters from India?

What is the total export value of sulfamethoxazole from India?

Which countries import sulfamethoxazole from India?

What is the HS code for sulfamethoxazole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of sulfamethoxazole exports from India?

Which ports handle sulfamethoxazole exports from India?

Why is India a leading exporter of sulfamethoxazole?

What certifications do Indian sulfamethoxazole exporters need?

How many buyers import sulfamethoxazole from India?

What is the market share of the top sulfamethoxazole exporter from India?

Analysis Methodology